Immunome, Inc.
IMNM
$15.67
-$0.82-4.97%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -43.40M | -41.64M | -80.25M | -47.10M | -36.12M |
| Total Depreciation and Amortization | 720.00K | 726.00K | 595.00K | 571.00K | 673.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 5.03M | 4.89M | 32.31M | 10.13M | 9.19M |
| Change in Net Operating Assets | -11.76M | -17.03M | 5.29M | 2.24M | 2.87M |
| Cash from Operations | -49.40M | -53.06M | -42.06M | -34.17M | -23.40M |
| Capital Expenditure | -905.00K | -3.67M | -1.38M | -47.63M | -2.34M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -63.27M | 8.75M | 11.13M | 71.72M | -79.34M |
| Cash from Investing | -64.17M | 5.09M | 9.76M | 24.10M | -81.69M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 215.00K | 172.71M | 20.49M | 509.00K | 1.16M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -270.00K | -10.49M | -400.00K | -204.00K | -469.00K |
| Cash from Financing | -55.00K | 162.23M | 20.09M | 305.00K | 694.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -113.63M | 114.26M | -12.22M | -9.76M | -104.39M |